Adalimumab in Pediatric Inflammatory Bowel Disease

Overview of attention for article published in Frontiers in Pediatrics, April 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 3,923 followers.

New Research: Adalimumab in Pediatric Inflammatory Bowel Disease: The introduction of biological agents with strong anti-inflammatory action, such as antitumor necrosis factor (TNF) agents, has changed inflammatory bowel disease (IBD)… https://t.co/7MMB9Dp

18 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.